|The Middle East and African pharmaceutical and consumer healthcare market is expected to grow at rates double that of the global markets. These emerging markets, therefore, make for an attractive business opportunity for new entrants to the region as well as for existing multinationals already present in the region to further grow their portfolios. This helps to compensate for slower growth rates in the more developed markets.|
The existing agents in the region are set up to provide a service for delivery of product to the point of sale, essentially a distribution/wholesale function. However, the distributors are not fully geared-up or experienced in delivery of marketing, medical, regulatory, pricing, sales or commercial functions to support the brands effectively.
The current model in the Middle East therefore can be limiting for many potential entrants to the region. For those companies who are already marketing their brands through distributors in the region but on an ‘export basis’ from home base do leave significant potential business untapped due to the shortfalls of the current distributor setup.
Dayarn Pharma helps fills this gap in the market with its expertise, experience and infrastructure.